Miner, Maurine D; Hatherill, Mark; Mave, Vidya; Gray, Glenda E; Nachman, Sharon; Read, Sarah W; White, Richard G; Hesseling, Anneke; Cobelens, Frank; Patel, Sheral; +22 more... Frick, Mike; Bailey, Theodore; Seder, Robert; Flynn, Joanne; Rengarajan, Jyothi; Kaushal, Deepak; Hanekom, Willem; Schmidt, Alexander C; Scriba, Thomas J; Nemes, Elisa; Andersen-Nissen, Erica; Landay, Alan; Dorman, Susan E; Aldrovandi, Grace; Cranmer, Lisa M; Day, Cheryl L; Garcia-Basteiro, Alberto L; Fiore-Gartland, Andrew; Mogg, Robin; Kublin, James G; Gupta, Amita; Churchyard, Gavin; (2022) Developing tuberculosis vaccines for people with HIV: consensus statements from an international expert panel. The lancet. HIV, 9 (11). e791-e800. ISSN 2405-4704 DOI: https://doi.org/10.1016/S2352-3018(22)00255-7
Permanent Identifier
Use this Digital Object Identifier when citing or linking to this resource.
Abstract
New tuberculosis vaccine candidates that are in the development pipeline need to be studied in people with HIV, who are at high risk of acquiring Mycobacterium tuberculosis infection and tuberculosis disease and tend to develop less robust vaccine-induced immune responses. To address the gaps in developing tuberculosis vaccines for people with HIV, a series of symposia was held that posed six framing questions to a panel of international experts: What is the use case or rationale for developing tuberculosis vaccines? What is the landscape of tuberculosis vaccines? Which vaccine candidates should be prioritised? What are the tuberculosis vaccine trial design considerations? What is the role of immunological correlates of protection? What are the gaps in preclinical models for studying tuberculosis vaccines? The international expert panel formulated consensus statements to each of the framing questions, with the intention of informing tuberculosis vaccine development and the prioritisation of clinical trials for inclusion of people with HIV.
Item Type | Article |
---|---|
Faculty and Department | Faculty of Epidemiology and Population Health > Dept of Infectious Disease Epidemiology & Dynamics (2023-) |
Research Centre |
Vaccine Centre TB Centre Centre for the Mathematical Modelling of Infectious Diseases TB Modelling Group |
PubMed ID | 36240834 |
Elements ID | 195956 |
Official URL | http://dx.doi.org/10.1016/s2352-3018(22)00255-7 |
Download
Filename: Miner-etal-Developing-tuberculosis-vaccines-for-people-with-HIV.pdf
Description: This is an author accepted manuscript version of an article accepted for publication, and following peer review. Please be aware that minor differences may exist between this version and the final version if you wish to cite from it.
Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 4.0
Download